Online citations, reference lists, and bibliographies.
← Back to Search

Potential Of Goat Probiotic To Bind Mutagens.

A. Apás, S. González, M. Arena
Published 2014 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
The mutagen binding ability of the goat probiotics (Lactobacillus reuteri DDL 19, Lactobacillus alimentarius DDL 48, Enterococcus faecium DDE 39, and Bifidobacterium bifidum DDBA) was evaluated. The oral administration of these probiotics reduced fecal mutagens and intestinal cancer markers in goats. Secondly, the effects of probiotics against the mutagenesis induced by sodium azide (SA), and Benzopyrene (B[α]P) by performing the modified Ames test using Salmonella typhimurium TA 100 was investigated. The capacity to bind benzopyrene and the stability of the bacterial-mutagen complex was analyzed by HPLC. The dismutagenic potential against both mutagens was proportional to probiotic concentration. Results showed that probiotic antimutagenic capacity against SA was ranging from 13 to 78%. The mixture of four goat probiotics (MGP) displayed higher antimutagenic activity against SA than any individual strains at the same cell concentration. This study shows that the highest diminution of mutagenicity in presence of B[α]P (74%) was observed in presence of MGP. The antimutagenic activity of nearly all the individual probiotic and the MGP were in concordance with the B[α]P binding determined by HPLC. According to our results, the B[α]P binding to probiotic was irreversible still after being washed with DMSO solution. The stability of the toxic compounds-bacterial cell binding is a key consideration when probiotic antimutagenic property is evaluated. MGP exhibits the ability to bind and detoxify potent mutagens, and this property can be useful in supplemented foods for goats since it can lead to the removal of potent mutagens and protect and enhance ruminal health and hence food safety of consumers.
This paper references
10.1016/0165-1161(75)90046-1
Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test.
B. Ames (1975)
10.1016/0165-1161(83)90010-9
Revised methods for the Salmonella mutagenicity test.
D. Maron (1983)
Inhibitory effect of Bifidobacterium longum on colon, mammary, and liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen.
B. Reddy (1993)
10.1080/1073161X.1993.10467179
Assessment of carcinogenic risk from personal exposure to benzo(a)pyrene in the Total Human Environmental Exposure Study (THEES).
J. P. Butler (1993)
10.1016/0027-5107(94)90313-1
Antimutagens as cancer chemopreventive agents in the diet.
L. Ferguson (1994)
10.3168/JDS.S0022-0302(94)77269-6
Antimutagenicity of fermented milk.
S. R. Nadathur (1994)
10.1080/01635589609514492
Lactobacillus- and bifidobacterium-mediated antigenotoxicity in the colon of rats.
B. Pool-Zobel (1996)
10.1016/S0278-6915(97)00029-X
Influence of carcinogen binding by lactic acid-producing bacteria on tissue distribution and in vivo mutagenicity of dietary carcinogens.
F. Bolognani (1997)
10.1139/CJM-44-11-1029
The antimutagenic properties of a polysaccharide produced by Bifidobacterium longum and its cultured milk against some heterocyclic amines
O. Sreekumar (1998)
10.1016/S0027-5107(97)00208-X
Antimutagenic properties of probiotic bacteria and of organic acids.
W. E. Lankaputhra (1998)
10.1016/S0027-5107(00)00064-6
The Ames Salmonella/microsome mutagenicity assay.
K. Mortelmans (2000)
10.1016/S0027-5107(01)00176-2
Impact of bacteria in dairy products and of the intestinal microflora on the genotoxic and carcinogenic effects of heterocyclic aromatic amines.
S. Knasmüller (2001)
10.1016/S1389-1723(02)80135-9
Antimutagenic activity of several probiotic bifidobacteria against Benzo[a]pyrene
Lo Pei-Ren (2002)
10.1016/J.IJFOODMICRO.2003.11.008
Determinations of the antimutagenic activities of several probiotic bifidobacteria under acidic and bile conditions against benzo[a]pyrene by a modified Ames test.
Pei-Ren Lo (2004)
10.1136/tc.2002.002816
Carcinogen derived biomarkers: applications in studies of human exposure to secondhand tobacco smoke
S. Hecht (2004)
10.1016/J.IJFOODMICRO.2004.11.015
Screening of potential lactobacilli antigenotoxicity by microbial and mammalian cell-based tests.
G. Caldini (2005)
10.1016/J.MRFMMM.2005.02.027
The potential mechanisms involved in the anti-carcinogenic action of probiotics.
D. Commane (2005)
Lactic acid bacteria as probiotics.
A. Ljungh (2006)
10.1002/mnfr.200700034
Binding of heterocyclic aromatic amines by lactic acid bacteria: results of a comprehensive screening trial.
R. Stidl (2008)
10.1016/J.FCT.2009.01.042
Screening of Lactobacillus casei strains for their ability to bind aflatoxin B1.
A. Hernández-Mendoza (2009)
10.1016/j.jbiosc.2010.06.005
Probiotic administration effect on fecal mutagenicity and microflora in the goat's gut.
A. Apás (2010)
10.1016/j.anaerobe.2011.07.001
In vitro mutagen binding and antimutagenic activity of human Lactobacillus rhamnosus 231.
P. Ambalam (2011)



This paper is referenced by
10.3389/fimmu.2021.736129
The Protection of Lactiplantibacillus plantarum CCFM8661 Against Benzopyrene-Induced Toxicity via Regulation of the Gut Microbiota
Leilei Yu (2021)
Postbiotics as Dynamic Biological Molecules and Their Antimicrobial Activity: A Review
A. H. Rad (2021)
10.1007/s12602-021-09810-7
The Ability of Probiotic Lactobacillus Strains in Removal of Benzo[a]pyrene: a Response Surface Methodology Study
M. Yousefi (2021)
10.1016/B978-0-12-819813-1.00004-9
Detoxification properties of microorganisms in foods
M. Yousefi (2021)
10.1016/B978-0-12-819662-5.00011-2
Probiotics and Prebiotics in Animal Feed
Mohamed Zommiti (2021)
10.1007/s00284-020-02100-5
In Vitro Studies on Therapeutic Potential of Probiotic Yeasts Isolated from Various Sources
M. Ragavan (2020)
10.1016/j.tifs.2019.12.012
Complicated interactions between bio-adsorbents and mycotoxins during mycotoxin adsorption: Current research and future prospects
Ying Luo (2020)
10.1016/j.tifs.2019.11.022
Interactions between probiotics and pathogenic microorganisms in hosts and foods: A review
A. M. Khaneghah (2020)
10.3390/toxins12120756
Aflatoxin B1 and Sterigmatocystin Binding Potential of Lactobacilli
J. Kosztik (2020)
10.1111/jam.14163
In vitro removal of polycyclic aromatic hydrocarbons by lactic acid bacteria
M. Yousefi (2019)
10.1007/s12602-019-09570-5
Probiotics—Live Biotherapeutics: a Story of Success, Limitations, and Future Prospects—Not Only for Humans
Mohamed Zommiti (2019)
10.2174/1573401314666180416120241
Probiotics and prebiotics as functional foods: state of the art
A. M. Khaneghah (2019)
10.3390/toxins11010049
Gut Microbiota Profiling of Aflatoxin B1-Induced Rats Treated with Lactobacillus casei Shirota
Winnie-Pui-Pui Liew (2019)
10.17576/JSKM-2018-16SI-04
Mutagenicity and Antimutagenic Activities of Lactic Acid Bacteria (LAB) Isolated from Fermented Durian (Tempoyak)
Asmariah Ahmad (2018)
10.3389/fmicb.2018.01503
The Binding Efficiency and Interaction of Lactobacillus casei Shirota Toward Aflatoxin B1
Winnie-Pui-Pui Liew (2018)
10.1007/978-3-319-71950-4_1
Probiotics and Prebiotics: An Overview on Recent Trends
G. Zoumpopoulou (2018)
10.1016/J.SMALLRUMRES.2018.02.009
Goat milk mutagenesis is influenced by probiotic administration
E. M. Utz (2018)
10.1007/s10529-017-2380-8
Autolyse the cell in order to save it? Inducing, then blocking, autolysis as a strategy for delaying cell death in the probiotic Lactobacillus reuteri
T. Zimmerman (2017)
10.1111/jgh.13861
Update on intestinal microbiota in Crohn's disease 2017: Mechanisms, clinical application, adverse reactions, and outlook
Zhaohua Shen (2017)
10.17795/IJCP-7920
Potential anticarcinogenic effects of lactic acid bacteria and probiotics in detoxification of process-induced food toxicants
N. Khorshidian (2016)
10.1186/s40781-016-0108-2
Probiotic isolates from unconventional sources: a review
P. Sornplang (2016)
10.22038/AJP.2016.5962
Protective role of Lactobacillus plantarum A7 against irinotecan-induced genotoxicity
S. Sepahi (2016)
10.3168/jds.2013-7805
Probiotic administration modifies the milk fatty acid profile, intestinal morphology, and intestinal fatty acid profile of goats.
A. Apás (2015)
Antitumor mechanisms of bifidobacteria ( Review )
Hongyun Wei ()
Semantic Scholar Logo Some data provided by SemanticScholar